Univariate analysis | Multivariate analysis | |||||
Predictor | Category | Overall survival | Hazard ratio | P | Hazard ratio | P |
Age (y) | <65 | 7.8 (5.8–11) | 0.9 (0.6–1.2) | 0.49 | NA | NA |
≥65 | 7.5 (5–9.4) | 1 | NA | |||
Sex | Female | 9.5 (5.3–13.7) | 0.9 (0.6–1.3) | 0.6 | NA | NA |
Male | 7.3 (5.8–8.5) | 1 | NA | |||
Albumin | >3.5 g/dL | 11.7–21 | 0.4 (0.2–0.7) | 0.002 | 0.7 (0.4–1.4) | 0.3 |
2.8–3.5 g/dL | 7.8 (6.4–11.4) | 0.7 (0.5–0.9) | 0.7 (0.5–1) | 0.07 | ||
<2.8 g/dL | 4.8 (4–7.7) | 1 | 1 | |||
Bilirubin | <2 mg/dL | 8 (7.3–11) | 0.15 (0.03–0.6) | <0.0001 | 0.16 (0.07–0.3) | <0.0001 |
2–3 mg/dL | 5 (2.2–9.7) | 0.24 (0.05–1.2) | 0.18 (0.07–0.43) | 0.0001 | ||
>3 mg/dL | 2 (1.2–3) | 1 | 1 | |||
Cirrhosis | Absent | 6.8 (6.2–8.9) | 0.95 (0.6–1.6) | 0.86 | NA | NA |
Present | 7.7 (5–20) | 1 | NA | |||
Ascites | Absent | 8.8 (7.7–12) | 0.6 (0.4–0.85) | 0.0015 | 0.6 (0.4–0.9) | 0.01 |
Present | 4.6 (3.5–6.4) | 1 | 1 | |||
Baseline tumor size | ≤5 cm | 13.9 (11–20) | 0.5 (0.4–0.75) | 0.0007 | 0.64 (0.42–0.97) | 0.037 |
>5 cm | 6.4 (5–7.8) | 1 | 1 | |||
Number of lesions | Solitary | 12.6 (7.7–19) | 0.6 (0.4–0.78) | 0.001 | 0.62 (0.4–0.98) | 0.04 |
Multifocal | 6.5 (5–7.9) | 1 | 1 | |||
Infiltration | Noninfiltrative | 12.6 (7.7–14) | 0.67 (0.5–0.9) | 0.01 | 1 (0.7–1.5) | 0.9 |
Infiltrative tumor | 6.2 (4.6–7.7) | 1 | 1 | |||
Tumor distribution | Unilobar | 9.4 (7.7–13.3) | 0.6 (0.4–0.8) | 0.0015 | 0.68 (0.46–1) | 0.068 |
Bilobar | 5 (4.5–6.5) | 1 | 1 | |||
AFP | <100 | 11.4 (7.9–13.9) | 0.7 (0.5–0.9) | 0.05 | 0.67 (0.5–0.96) | 0.03 |
≥100 | 6.5 (5–7.7) | 1 | 1 | |||
ECOG | 0 | 8 (6.7–13.8) | 0.32 (0.14–0.78) | 0.0001 | 0.44 (0.24–0.8) | 0.01 |
1 | 7.7 (5.2–9.5) | 0.35 (0.15–0.8) | 0.39 (0.22–0.7) | 0.001 | ||
2 | 2.5 (2–4.6) | 1 | 1 | |||
PVT extent | Segmental | 13.8 (8.5–15.7) | 0.54 (0.36–0.8) | 0.008 | 0.8 (0.5–1.3) | 0.4 |
Lobar | 7.7 (5.3–10.4) | 0.7 (0.5–1) | 0.8 (0.5–1.2) | 0.2 | ||
Main | 5 (4–7.7) | 1 | 1 |
NA = not applicable; ECOG = Eastern Cooperative Oncology Group.
Data in parentheses are 95% CI.